[
  {
    "ts": "2026-02-26T02:13:14+00:00",
    "headline": "DexCom Weighs GLP 1 CGM Tailwind Against Valuation And Momentum Signals",
    "summary": "DexCom (NasdaqGS:DXCM) is seeing higher adoption of its continuous glucose monitoring systems among patients using GLP-1 drugs, as physicians pair both therapies for diabetes care. The company is refining its product lineup, with management expecting the 15 day G7 CGM system to take a leading role within its portfolio. These developments are material for investors because they relate to DexCom's growth paths across domestic and international CGM markets beyond standard earnings...",
    "url": "https://finance.yahoo.com/news/dexcom-weighs-glp-1-cgm-021314708.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "6e0a8ba7-0188-3153-bb07-1ac8b5020c16",
      "content": {
        "id": "6e0a8ba7-0188-3153-bb07-1ac8b5020c16",
        "contentType": "STORY",
        "title": "DexCom Weighs GLP 1 CGM Tailwind Against Valuation And Momentum Signals",
        "description": "",
        "summary": "DexCom (NasdaqGS:DXCM) is seeing higher adoption of its continuous glucose monitoring systems among patients using GLP-1 drugs, as physicians pair both therapies for diabetes care. The company is refining its product lineup, with management expecting the 15 day G7 CGM system to take a leading role within its portfolio. These developments are material for investors because they relate to DexCom's growth paths across domestic and international CGM markets beyond standard earnings...",
        "pubDate": "2026-02-26T02:13:14Z",
        "displayTime": "2026-02-26T02:13:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/qYSQ6AG4c18KIEG8bfQS1g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/mH32bjf22B8VXoaGCZudBg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/b23fe2923663ce315e2ef7ba313db8b9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-weighs-glp-1-cgm-021314708.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/dexcom-weighs-glp-1-cgm-021314708.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "DXCM"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]